Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 35 (RPS2P35) is a processed pseudogene located on human chromosome 9, annotated under NCBI Gene ID 100130980[2][6][7]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, truncations, or lack of regulatory elements; they do not encode proteins and are not drug targets. RPS2P35 originates from the ribosomal protein S2 gene, which encodes a structural component of the 40S ribosomal subunit, but RPS2P35 itself does not contribute to protein synthesis, does not participate in biological pathways, and has no known function, disease association, or role as a therapeutic target. Its presence reflects genome evolution and gene duplication rather than functional biology[2][7][8]. Summary: RPS2P35 is a non-coding pseudogene with no experimental evidence of protein expression, functional activity, disease association, or druggability. It is strictly a genomic remnant and not a valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 35 (RPS2P35).